Clinical Trials
22 trialsNCT05663502 2026-06-01
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
AIDS Malignancy Consortium
Recruiting
NCT05863195 2026-06-01
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Eastern Cooperative Oncology Group
Phase 3 Recruiting
NCT04239573 2026-05-27
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Eastern Cooperative Oncology Group
Phase NA Recruiting
NCT06998940 2026-05-22
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
SWOG Cancer Research Network
Phase 3 Recruiting
NCT06976710 2026-05-20
PC2
Surgical Outcomes Research Centre (SOuRCe)
Phase NA Recruiting
NCT07058012 2026-05-15
EMPIRE
NSABP Foundation Inc
Phase 2 Recruiting
NCT06205485 2026-05-12
NEO-RT
Canadian Cancer Trials Group
Phase 3 Recruiting
NCT07152821 2026-05-12
BATTMAN
Canadian Cancer Trials Group
Phase 3 Recruiting
NCT06290505 2026-05-08
PALEO
Australasian Gastro-Intestinal Trials Group
Phase 2 Recruiting
NCT05108298 2026-05-07
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Eastern Cooperative Oncology Group
Phase NA Recruiting
NCT06441747 2026-05-06
Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)
Australasian Gastro-Intestinal Trials Group
Phase 2 Recruiting
NCT04851119 2026-05-05
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Phase 1/2 Recruiting
NCT06620302 2026-05-05
Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma
Children's Oncology Group
Phase 1/2 Recruiting
NCT06880523 2026-04-14
SLIDE-HCC
Canadian Cancer Trials Group
Phase 2 Recruiting
NCT06807437 2026-03-31
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
SWOG Cancer Research Network
Phase 3 Recruiting
NCT07018869 2026-03-31
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
SWOG Cancer Research Network
Phase 3 Recruiting
NCT02598349 2025-09-09
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas
Proton Collaborative Group
Phase 2 Recruiting
NCT06462963 2025-08-01
SPRINT
European Organisation for Research and Treatment of Cancer - EORTC
Phase NA Recruiting
NCT06149546 2025-07-08
FEED
Cancer Trials Ireland
Phase NA Recruiting
NCT04498767 2024-08-26
OligoRARE
European Organisation for Research and Treatment of Cancer - EORTC
Phase NA Recruiting
NCT04282083 2024-01-25
Protocol ITANET - Registry
Italian Association Neuroendocrine Tumors
Recruiting
NCT05935189 2023-07-07
TIR-HCC
Nikomed Medical Center
Recruiting